Inventor · disambiguated record
Mohammed Ghonime
Also filed as: GHONIME MOHAMMED
4 granted patents·5 pending applications·3 citations·filing 2021–2025
67Inventor score
Files withCRISPR THERAPEUTICS AG9
Top patents by PatentIndex Score
9 records- 0193US11497773B2Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistenceCRISPR THERAPEUTICS AG·Filed 2021·Granted Nov 15, 2022·2 cites·20 claims
- 0289US11679130B2Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistenceCRISPR THERAPEUTICS AG·Filed 2021·Granted Jun 20, 2023·1 cites·29 claims
- 0382US11857574B2Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistenceCRISPR THERAPEUTICS AG·Filed 2022·Granted Jan 2, 2024·0 cites·21 claims
- 0477US11679131B2Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistenceCRISPR THERAPEUTICS AG·Filed 2021·Granted Jun 20, 2023·0 cites·29 claims
- 0574US2022090012A1Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistenceCRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0674US2025179146A1Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistenceCRISPR THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 0762US2023303713A1Anti-cd19 car-t cells with multiple gene edits and therapeutic uses thereofCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0858US2023046228A1Methods for manufacturing genetically engineered car-t cellsCRISPR THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0955US2021363212A1Genetically engineered car t cells that secret interleukin-12 and therapeutic uses thereofCRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →